No headlines found.
Globe Newswire (Thu, 29-Jan 9:00 AM ET)
Globe Newswire (Tue, 6-Jan 9:00 AM ET)
Globe Newswire (Mon, 5-Jan 9:00 AM ET)
Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference
Globe Newswire (Thu, 18-Dec 9:00 AM ET)
Globe Newswire (Tue, 9-Dec 9:00 AM ET)
Globe Newswire (Thu, 4-Dec 9:00 AM ET)
Globe Newswire (Tue, 2-Dec 9:00 AM ET)
Alpha Tau to Participate in December Investor Conferences
Globe Newswire (Mon, 1-Dec 9:00 AM ET)
Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Globe Newswire (Thu, 20-Nov 4:05 PM ET)
Alpha Tau to Participate at Jefferies Global Healthcare Conference in London
Globe Newswire (Tue, 11-Nov 8:30 AM ET)
Alpha Tau Medical Ltd. - Warrant trades on the stock market under the symbol DRTSW.
As of February 2, 2026, DRTSW stock price declined to $0.87 with 6,998 million shares trading.
DRTSW has a beta of 0.54, meaning it tends to be less sensitive to market movements. DRTSW has a correlation of 0.01 to the broad based SPY ETF.
DRTSW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, DRTSW traded as high as $1.18 and as low as $.09.
DRTSW has outperformed the market in the last year with a return of +123.1%, while the SPY ETF gained +16.1%. In the last 3 month period, DRTSW beat the market returning +172.0%, while SPY returned +2.6%. However, in the most recent 2 weeks DRTSW has underperformed the stock market by returning -8.4%, while SPY returned +0.5%.
DRTSW support price is $.76 and resistance is $1.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DRTSW shares will trade within this expected range on the day.
